Olga Meltem Akay

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 375 citations · Full text

Hematological Malignancy, Medicine, Hematology +6

Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography

Olga Meltem Akay, Zeki Üstüner, Zerrin Cantürk et al. · Medical Oncology · 2008 · 106 citations

Thrombosis, Heart Failure, Venous Thrombosis +8

Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism

Deborah Lewis, Gregg J. Stashenko, Olga Meltem Akay et al. · Thrombosis Research · 2011 · 53 citations · Full text

Thrombopoiesis, Pulmonary Embolism, Thrombosis +11

Pesg PNH diagnosis, follow-up and treatment guidelines.

Fahri Şahin, Olga Meltem Akay, Mesut Ayer et al. · PubMed · 2016 · 49 citations · Full text

Disease Diagnosis, Urology, Study Group +14

Can thrombelastography be a new tool to assess bleeding risk in patients with idiopathic thrombocytopenic purpura?

Eren Gündüz, Olga Meltem Akay, Cengiz Bal et al. · Platelets · 2011 · 30 citations

New Tool, Diagnosis, Pathology +22